Ultram Generic Labeling Should Require 25 Mg Titration Regimen, J&J Says
Johnson & Johnson is willing to waive its exclusivity for the protected 25 mg titration schedule for Ultram (tramadol) if FDA makes a determination that that schedule is superior to the 50 mg titration regimen
You may also be interested in...
FDA is approving Ultram (tramadol) generics with labeling that includes the 50 mg titration regimen, but not the protected 25 mg titration schedule
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials